Prof Georgina Long awarded Eureka Prize for Scientific Research
Read more about the Australian Museum 2026 Eureka Prizes and the transformative scientific research led by Professor Long.
Maria Gonzalez appointed CEO of Melanoma Institute Australia
The Board of MIA has appointed Maria Gonzalez as Chief Executive Officer following a comprehensive external search. Maria has led MIA as Interim CEO since December 2025. Read more about how Maria has been a senior leadership team member at MIA for sixteen years, helping build the organisation.
Location and type of immune cells affects treatment response
Read more about how researchers at Melanoma Institute Australia and The University of Sydney have led the way in showing that it’s not just the number of immune cells in a tumour that influences treatment response - it’s also where those cells are located and their type.
MIA team share learnings at key international conferences
Read more about how the MIA team continues to play a leading role in advancing the frontiers of melanoma research, presenting new findings at major international oncology conferences - the AACR Annual Meeting in San Diego, the EADO Congress in Prague, and ASCO in Chicago.
Update Newsletter – 13 May 2026
Roadmap Workstreams have been meeting regularly to discuss and define key elements of a potential screening program design and evaluate available evidence. Read the latest update on progress to date.
Roadmap Annual Collaborators Meeting 27 March 2026
The Roadmap Annual Collaborators Meeting was hosted by MIA on 27 March 2026. Read more and view the Summary Report of the meeting.
Streamlining assessment of pathological response after neoadjuvant treatment
Neoadjuvant immunotherapy continues to transform outcomes for people with melanoma and other cancers. Two recent papers show that assessing pathological response after neoadjuvant immunotherapy can be both more efficient and more consistent, without compromising accuracy.
Melanoma March 2026 in pictures
See all the photos from our Melanoma March 2026 events, and download yours.
Helen Godwin
Inspired by the work of Melanoma Institute Australia, Helen Godwin decided to support MIA through a bequest in her will. Her family recently visited MIA’s Translational Research Laboratory at Charles Perkins Centre (University of Sydney) and heard first-hand how Helen’s generosity will help support melanoma research projects, and ensure her legacy will make a lasting difference.
Karen Smith
Karen Smith is a Senior Clinical Data Manager at Melanoma Institute Australia (MIA), based at Westmead Hospital. Read on to learn what it means to be a clinical data manager, Karen's career journey and more!